COR earnings date and last-quarter result: last quarter beat, P/E 22.91. Updated 2026-07-23.
Cencora (COR) Research Hub
Cencora (COR) trades on NYSE, US in the Healthcare (Medical - Distribution) sector. As of 2026-10-26, shares last closed at 330 USD (-0.30%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 22.91, market cap 58.83B. This hub links to the full technical, earnings and options research available for COR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Distribution) |
|---|---|
| Exchange | NYSE, US |
| Last close | 330 USD (-0.30%) |
| 52-week range | 269.3 USD – 345.43 USD |
| Trend regime | Range |
| 14-day RSI | 65.9 (Bullish) |
| Trailing P/E | 22.91 |
| Market cap | 58.83B |
| Dividend yield | 0.78% |
Available research for COR
Covered Call on COR: how it works, illustrative setup around the real 330 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on COR: how it works, illustrative setup around the real 330 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on COR: how it works, illustrative setup around the real 330 USD price, max profit/loss, breakeven and when to use it. Educational.
COR technical analysis: range, last 330 USD, RSI 65.9, 52w range 269.3 USD–345.43 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is COR in?
Cencora (COR) is classified under Healthcare (Medical - Distribution), listed on NYSE, US.
Is COR in an uptrend or downtrend?
As of 2026-10-26, COR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is COR's trailing P/E ratio?
COR's trailing P/E is 22.91, with a market cap of 58.83B. See the earnings research page for full valuation detail.